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Abstract
Purpose: To assess differentiating features between bacterial, Aspergillus, and Mucor skull base osteomyelitis (SBO) 
with regard to clinical presentation and imaging appearances.  
Material and methods: A literature search was performed in April 2020 for studies on SBO with a minimum sample 
size of 10 patients. Studies that reported presenting symptoms, cross-sectional imaging findings, complications, and 
mortality were included in the analysis. The quality of included articles was tested using the Quality Assessment  
of Diagnostic Accuracy Studies 2 tool. A data extraction form was used to retrieve relevant parameters from each 
of the articles. 
Results: Thirteen articles were included in the final analysis. Diabetes mellitus was the most common predisposing 
factor (12.5-91.0%). Presenting complaints in all bacterial SBO studies were otogenic, while fungal SBO patients had 
nasal/ocular complaints. Rates of mortality and surgical intervention in the fungal group were 50-100% and 50%, 
respectively, as compared to the bacterial group – 7-87% and 10%, respectively. On imaging, the site of initial infec-
tion in bacterial SBO was the external auditory canal, while in fungal SBO it was the paranasal sinus. The incidence 
of orbital extension was < 5% in bacterial and 44-70% in fungal SBO, among which Mucor had rates of 65-70%. Bone 
erosion was less extensive in bacterial SBO, and the patterns differed. The highest incidence of vascular involvement 
and non-enhancing lesions (23-36%) was seen in Mucor. Aspergillus showed highest sino-cranial extension (52-55%) 
and homogenous bright enhancement.   
Conclusions: Systematic analysis of the clinico-radiological parameters in each of the studies revealed differences in 
presentation, clinical course, extension, bone erosion, and enhancement. 
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Introduction
Skull base osteomyelitis (SBO), although an uncommon 
clinical entity, poses a significant challenge to most clini-
cians because of its unpredictable clinical course and often 
lethal nature. The disease is often seen in conjunction with 
aggressive infectious pathologies of the head and neck; 
mainly otitis media, otitis externa, and rhinosinusitis [1]. 
These often progress in patients with underlying risk fac-
tors, such as diabetes mellitus and immunosuppression. 
However, the clinical presentation is in itself non-specific, 
with a myriad of signs and symptoms including headache, 
orbital congestion, and cranial nerve palsies [2]. There-
fore, imaging remains the mainstay of diagnosis and prog-
nostication of this sinister complication.  
Bacteria (predominantly Pseudomonas aeruginosa and 
Staphylococcus aureus) [1] and fungi of the Aspergillus sp. [3] 
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and Mucorales (Rhizopus and Mucor spp.) [4] have emerged as 
the foremost aetiological agents for SBO, although anecdotal 
reports of several other organisms exist. Multiple investiga-
tors have highlighted differences in the management strategy 
amongst the 2 groups, with fungal SBO requiring surgical in-
tervention in addition to the obvious variation in antimicro-
bial therapy for both groups [5]. In addition, even among the 
fungal species, it has been observed that Mucorales (Mucor) 
have a far more fulminant course, higher instance of complica-
tions, and need for surgical debridement, in comparison to the 
Aspergillus sp. [6]. It becomes imperative, therefore, to provide 
an imaging-based aetiological classification to aid in manage-
ment. This is particularly important because surgical biopsy 
is often not feasible due to the anatomical complexity of this 
region, as well as low patient tolerance. The positivity rates of 
microbial cultures are also low [7]. 
While several authors have reported varying presenta-
tions of both fungal as well as bacterial SBO, these exist 
mostly as isolated case reports. Only a few series involving 
large patient subsets exist in the literature. There is also 
a paucity of studies comparing the different presentations 
or imaging features of the culprit organisms. We aim to 
address these issues by evaluating the reported clinical, 
as well as radiological, parameters of the index studies in 
cases of SBO.  
Material and methods
This systematic review was conducted as per the PRISMA 
guidelines [8]. 
Eligibility criteria
The studies were required to fulfil the following criteria 
to be considered for this systematic review: 1) imaging 
features on at least 1 cross-sectional imaging modality 
(either CT or MRI) reported; 2) inclusion of clinical pa-
rameters including underlying immunosuppression, pre-
senting complaints and/or treatment strategy, mortality, 
etc.; 3) full text of article available in English language; 
and 4) exclusion of review articles, case reports, pictorial 
essays, and letters to the editor.
Information sources
The PubMed and Google Scholar databases were searched in 
April 2020 for studies which satisfied the eligibility criteria. 
The keywords used were: ‘skull base osteomyelitis’ or ‘skull 
base’ AND ‘radiology’ or ‘imaging’ AND ‘fungal’ or ‘bacte-
rial’. The title as well as abstracts of the studies were exam-
ined by reviewers for inclusion in the study. The identified 
articles were retrieved, and a manual search of bibliography 
was done to identify other potentially relevant studies. Fol-
lowing this, the search keywords were expanded to include 
‘rhino-orbito-cerebral mucormycosis’ or ‘craniocerebral as-
pergillosis’ AND ‘imaging’ or ‘MRI’ or ‘magnetic resonance 
imaging’. An additional search of Embase was done using the 
same keywords as above. 
Final study selection
Using these search criteria, initially 547 articles were iden-
tified. We excluded duplicate articles, review articles, case 
reports, pictorial essays, and letters to the editor. We also 
excluded articles that did not give details of radiologi-
cal parameters assessed and those in which the full text 
could not be obtained despite our best efforts. It was also 
decided to exclude case series with less than 10 patients, 
because we felt these were not truly representative. We 
also excluded articles that reported only intracerebral as-
pergillosis, because this differed from our primary aim of 
describing SBO imaging findings. 
Data extraction
We examined the included studies for study design, par-
ticipants, and imaging modalities used. A data extraction 
form was used to grade the level of evidence and bias by 
2 radiologists. Disputes were settled through consensus 
approach. The level of evidence was graded using the 
guidelines for diagnostic tests by the Oxford Centre for 
Evidence-Based Medicine [9]. The Quality Assessment 
of Diagnostic Accuracy Studies 2 (QUADAS-2) tool [10] 
was used to determine risk of bias and concerns of appli-
cability. 
Following this, we entered all relevant clinical and ra-
diological parameters of the studies in the form. Clinical 
parameters assessed included the mean age/age range of 
participants, predisposing conditions causing immune 
compromise, patient presentation, treatment strategy 
used, and mortality. Imaging parameters detailed in-
clude- site of initial infection, bone erosion, orbital ex-
tension, intracranial extension, vascular complications 
and any other relevant findings including deep exten-
sion, enhancement patterns, and MRI signal characteris-
tics. If a study was limited to a certain subset of patients 
(e.g. orbital disease only) and extension to other subsites 
was not detailed, the remaining parameters were not de-
scribed. However, if the study did not describe any such 
subsite limitation but information on certain parameters 
(e.g. orbital extension) was missing, it was assumed as 
being absent and we labelled it as ‘not reported’. Due to 
the heterogeneity of data and lack of complete informa-
tion in both clinical and imaging data, we did not attempt 
a meta-analysis. 
Summary measures and synthesis of results
Based on the data extracted from the included studies, 
we prepared comparative charts to derive the difference in 
clinical presentation, as well imaging features of bacterial 
SBO and fungal SBO. 
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Results
Literature search and study selection
Using the search criteria, initially 547 articles were iden-
tified. After screening titles and abstracts and removing 
duplicate articles, we shortlisted 42 articles. Of these, we 
could not find the full text of 3 articles in English lan-
guage despite our best attempts. The full text of 39 articles 
was scanned by 2 radiologists. Of these, 14 articles did 
not describe cross-sectional imaging findings, another 
4 had sample size of less than 10, and 8 dealt only with al-
lergic fungal rhinosinusitis or intracerebral aspergillosis. 
Finally, 13 articles were selected for the study. Of these, 
9 reported fungal SBO [2,11-18], 2 reported bacterial SBO 
[7,19], and another 2 had patients with both organisms 
[20,21]. The search methodology is detailed in Figure 1. 
QUADAS 2 assessment
The details of studies included are provided in Table 1. 
The study design, number of patients, and level of evi-
dence is detailed. The risk of bias and applicability con-
cerns are also mentioned. Overall, 12 studies had risk of 
bias. The chief domain among bias risk was the patient se-
lection and interpretation of index test results, due to the 
retrospective design of the studies. The patient selection 
was not consecutive/random, and the results of reference 
standard were available to interpreting diagnosticians. 
None of the studies had bias in the reference standard. 
Clinical parameters
The clinical details extracted from the studies are listed in 
Table 2. A wide age range was seen among studies report-
ing both bacterial as well as fungal aetiologies. However, 
we observed that there was relative sparing of the paedia-
tric population, with only 3/13 studies reporting inclu-
sion of children less than 5 years old (1 from the bacterial 
group [19] and 2 from the Mucor group [2,13]). 3/13 stud-
ies had immune-competent patients in varying numbers 
[11-13], while the rest had only immune-compromised 
patients. Of these, 2 studies with Aspergillus SBO recruited 
only immune-competent patients [11,12]. The most con-
sistent predisposing factor among the 11/13 studies who 
had patients with some degree of immune compromise 
was diabetes mellitus, present in proportions ranging 
from 12.5 to 91%, with highest proportions reported in 
the Mucor study groups (21-91%) [2,13,16,18,20]. Others 
included haematological disorders, steroid use, and im-
munosuppressive drugs.
Among all the studies reporting purely bacterial ae-
tiology SBO, the presenting complaints were otogenic 
[7,19,21], while among the studies reporting purely fun-
gal aetiology, complaints varied and included headache, 
nasal discharge/stuffiness, and ocular symptoms such 
as pain or ophthalmoplegia [2,11,12,14-18]. One of the 
studies dealt only with orbital manifestations and there-
fore reported ocular complaints in 100% of patients [20]. 
The characteristic black necrotic lesions or ‘eschar’ was seen 
in 3/13 studies, of which all had patients with Mucor SBO 
[13,14,17]. On comparison of incidence of cranial nerve 
palsies amongst groups, studies with bacterial SBO report-
ed 33-100% incidence [7,19,21], while those with Mucor 
SBO and Aspergillus SBO reported 10-83% [2,13,16,17] and 
approximately 18-30% [11,12,15], respectively. 
In terms of the management strategy used, the rates 
for surgical intervention in bacterial SBO were between 
7 and 87% [19,21], while those in fungal SBO were higher, 
ranging from 50 to 100% [11,13-18]. Antimicrobial strat-
PubMed, Google Scholar and EMBASE search in April 2020 using keywords 'skull base osteomyelitis' or 'skull base'  
AND 'imaging' or 'radiology' AND 'fungal' or 'bacterial'. Followed by 'rhino-orbitocerebral mycoses' or 'craniocerebral 
aspergillosis' and 'radiology' or 'imaging' or 'MRI' or 'magnetic resonance imaging'. 
Manual search of bibliographies of articles meeting eligibility criteria. 
Both bacterial  
and fungal: 2
Duplicate articles, review articles, 
case reports, case series and letters 
to editor: 505
Fungal: 9 
(Aspergillus: 3, Mucorales: 5, 
both Aspergillus and Mucorales: 1)
Articles not describing radiology: 14 
Full text not available: 3
Less than 10 sample size: 4 






Figure 1.  Search strategy for study inclusion
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egy for fungal SBO caused by Aspergillus sp. involved 
the use of oral triazole therapy for 5-7 months in addi-
tion to the initial use of Amphotericin B intravenously, 
or even oral therapy in isolation when no intracranial 
extension was present [11,12,21]. For Mucor, antifungal 
therapy consisted of intravenous Amphotericin B only, 
with liposomal form used in the newer study [18]. Hyper-
baric oxygen was used in only 2 of the studies [16,19]. 
The mortality rates were also different for both groups. 
Fungal SBO had higher mortality, particularly amongst 
patients who did not undergo surgery and those who had 
intracranial extension. The rates were as high as 50% in 
4 studies [14,16-18], while for bacterial SBO the maxi-
mum mortality was close to 10% [7]. 
Imaging parameters
The details of imaging features extracted from the 
studies are listed in Table 3. There was a clear predilec-
tion regarding the predominant site of involvement, 
with bacterial aetiology favouring otogenic involve-
ment – most commonly the EAC but also the middle 
ear. Fungal aetio logy, on the other hand, showed a pre-
dominant paranasal sinus (PNS) involvement. This 
involvement was commonly in the form of mucosal 
thickening in sinuses, as reported in 5 studies of fun-
gal SBO [2,12,16,18,20]. Ethmoid sinus was most fre-
quently affected in 3 of these studies [2,13,15], while 
maxillary sinus was the favoured site in 1 study [16]. 
The reported incidence of orbital involvement in bac-
terial SBO was < 5% [7], whereas fungal SBO showed 
orbital extension in the range of 44-76% [2,13,15-18]. 
There was a greater incidence of orbital extension in Mu-
cor SBO, with most studies reporting 65-70% involve-
ment [2,14,16-18]. Half of the studies with fungal SBO 
used a classification system based on extension of disease; 
wherein subsites of involvement (sinus, orbit, cranium, 
deep tissues) were considered [2,11-13,15,18]. It was ob-
served that Aspergillus studies showed a higher propor-
tion of patients with sino-cranial extension of disease 
[11,12,15], while Mucor studies showed greater preponder-
ance of sino-orbital or sino-orbito-cranial forms [2,13,18]. 
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Table 2. Clinical details of patients in included studies
Criteria Mean age 
(range) 
in years
Predisposing factors Presentation Treatment Mortality Cranial nerve 
palsy
Mejzlik [7] 78 DM: 50.0%
Renal failure: 33.3%
Pulmonary disease: 33.3%
EAC infection: 100.0% Systemic antibiotics based 
on C/S ± mastoidectomy













   Mucor 63.2 ± 10.9 DM: 71.4%
HTN: 57.1%
Others: 28.6%




















Le Clerc [21] – DM Otalgia: 83.0%
Otorrhea: 83.0%
Nil 47% (CN VII)




   Bacteria CFR: 138 ± 81 days










Nil 35% (CN VII) 
Siddiqui [12] 31.1 (14-74) Immune competent 3(15%) 30%
   Type 1* Headache, papilledema, CN deficit, 
convulsions
Surgery (100%) 3 (50%)
   Type 2* Headache, nasal stuffiness, discharge, 
loss of vision, impaired consciousness
IV Amp B + oral itraconazole Nil
   Type 3* Nasal stuffiness, discharge, diplopia, 
visual loss
Oral itraconazole Nil
Siddiqui [11] 36.5 (14-74) Immune competent Nasal stuffiness: 52.0%
Headache: 40.0%
Proptosis: 36.0%














Ocular complaints (proptosis, 










II, III, IV > VI 
> V
Murthy [15] 41.8 (19-65) DM: 12.5% CS syndrome: 31.3%
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Criteria Mean age 
(range) 
in years
Predisposing factors Presentation Treatment Mortality Cranial nerve 
palsy
Talmi [14] 60 (34-87) Haematological: 63.2%
DM: 21.1%
Eschar: 94.7%
Ocular complaints (chemosis, 
proptosis, ophthalmoplegia,  










Gamba [16] 57.2 (32-80) DM: 90% Ocular complaints (proptosis, 





50% 10% (CN VII)
Centeno [17] 18-75 DM: 75.0%
Steroid: 8.3%
Haematological: 8.3%











III, IV, V1, V2, VI: 
58.3%
VII-X: 25%
DM – diabetes mellitus, EAC – external auditory canal, C/S – culture/sensitivity, HTN – hypertension, EOM – extraocular muscle, Amp B – amphotericin B, IV – intravenous, CFR – ciprofloxacin resistant, 
CFS – ciprofloxacin sensitive
*Type I – intracerebral extension, Type II – intracranial extradural extension, Type III – skull base/orbital invasion only
Table 3. Radiological details of patients in included studies
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 Can imaging suggest the aetiology in skull base osteomyelitis? A systematic literature review
e315© Pol J Radiol 2021; 86: e309-e321



















Meningitis: 1 Not 
reported
– –
Siddiqui [12] – + Present Sinus walls/ cranial 
base-85%
4% (CS) – Calcification (15%)
Type I* Sino-cranial: 55% 30%
Type II* – 25%
Type III* Sino-orbital: 45% –
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a) MR lateral 
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41.7%















EAC – external auditory canal, PNS – paranasal sinus, CS – cavernous sinus, Enh – enhancement, ICA – internal carotid artery, SOV – superior ophthalmic vein, HCP – hydrocephalus, IJV – internal jugular vein, 
OM – osteomyelitis, MR – medial rectus, ON – optic nerve, PPF – pterygopalatine fossa, ITF – infratemporal fossa. *Type I – intracerebral extension, Type II – intracranial extradural extension, Type III – skull 
base/orbital invasion only
Table 3. Cont.
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Bone erosion was seen among 5/9 studies on fun-
gal SBO, with incidence ranging from 25% to 85% 
[2,11,12,16,17]. Three studies on bacterial SBO also re-
ported the presence of erosions. It was described as a late 
finding in one of these [7], while another one described 
lesser extent of erosions in comparison to fungal SBO [21]. 
Vascular involvement and intracranial complications 
were both widespread in fungal SBO, whereas only anecdotal 
reports of these complications were seen in bacterial SBO. 
Amongst the intracranial complications, dural-based intra-
cranial masses were seen more frequently in Aspergillus sp. 
[11,12,15], whereas Mucor had higher incidence of brain ab-
scess or infarct [2,14,16-18]. Vascular complications were also 
seen more frequently in Mucor patients, with cavernous sinus 
thrombosis being the most frequent finding [2,13,14,16,17]. 
Superior ophthalmic vein thrombosis was seen in 2 stud-
ies of Mucor SBO [14,16]. Another relevant finding to note 
was the enhancement characteristics of the lesions. Mucor 
had a higher incidence of mild or non-enhancing mucosa 
on CT (> 90%) and heterogenous enhancement on MRI [2]. 
Aspergillus, on the other hand, showed homogenous bright 
enhancement in some studies, and mixed enhancement in 
the others [12,15]. MRI signal was detailed in 2 studies on 
fungal SBO. Both of these showed T1 and T2 hypointensity 
of the fungal lesions in varying numbers ranging from 
35 to 100% [2,11]. 
Discussion
We performed this study with a view to differentiate 
between the clinical as well as cross-sectional imaging 
features of bacterial, Aspergillus, and Mucor SBO. A geo-
graphical trend of incidence was observed in our study, 
whereby most studies (reporting fungal SBO in partic-
ular) were from East Asia. A tropical climate has been 
reported to increase the incidence of Aspergillus SBO in 
immune-competent hosts [22]. 
Bacterial SBO is usually secondary to malignant oti-
tis externa, leading to osteomyelitis of the temporal bone, 
which spreads across the tympanomastoid suture to af-
fect the central skull base [7] (Figure 2). Mucorales SBO, 
on the other hand, is caused by inhalation of spores of 
Figure 2. Bacterial skull base osteomyelitis (SBO). A-C) 62-year-old male with bacterial SBO. A) Coronal unenhanced computed tomography (CT) shows 
soft tissue in the left external auditory canal (solid arrow) as well as the middle ear cavity (arrow). The inferior aspect of the petrous apex shows irregu-
larity (arrowhead). B) Axial T2 FS MR shows T2 hyperintense soft tissue in the EAC (arrows), corresponding to the CT. Mastoid air cells are also fluid filled 
(arrowhead). T2 hyperintensity in the petrous apex, clivus and mandibular condyle (solid arrows) suggests marrow edema. C) T1 FS post gad image shows 
enhancement in the clivus and the jugular fossa (solid arrows). D) 54-year-old female with bacterial SBO. Axial T1 FS post gad MR shows enhancing soft 
tissue involving the EAC, middle ear cavity and mastoid (solid arrows). Enhancing soft tissue is also at the petrous apex encasing the left internal carotid 
artery (arrows), which however shows normal calibre. Note the clear paranasal sinuses (*). E) 23-year-old female with chronic otitis media complicated 
by SBO. Axial T1 post gad image shows enhancement of the petrous apex (solid arrows) and the vestibulocochlear nerve complex in the internal auditory 
canal (arrows). Note the opacification of middle ear and mastoid air cells (*)
A B C
D E
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the organism, which become pathogenic and invasive 
in immunocompromised individuals. Aspergillus is also 
a frequent contaminant of the nasal cavity, and it may ex-
ist both in invasive and non-invasive forms. The impetus 
for saprophytic Aspergillus to become pathogenic may be 
provided by chronic obstruction of the nose or PNS [23]. 
However, in addition to this, there is a significant propor-
tion of craniocerebral aspergillosis that may be caused by 
haematogenous dissemination from the more common 
manifestation of invasive aspergillosis, i.e. pulmonary 
infections. Thus, in keeping with the pathophysiology, 
bacterial SBO showed predominantly otogenic involve-
ment, while fungal SBO presented with a wider range of 
nasal/ocular complaints. The incidence of cranial neu-
ropathies was similar in both groups, but the patterns 
differed. Because bacterial SBO tends to spread from the 
temporal bone inwards, there was a higher incidence of 
palsy of facial nerves (CN VII) in the initial presentation, 
with later involvement of CNs VIII-XII (Figure 2E). On 
the other hand, since fungal SBO spreads from PNS up-
wards and also tends to involve the cavernous sinus, there 
was a greater incidence of palsies of CNs III, IV, V1, V2, 
and VI. Bacterial SBO showed good clinical response to 
antibiotics. Mastoidectomy was required only in cases 
with extensive disease on imaging or in those with clini-
cal progression despite antibiotic therapy. Fungal SBO, 
however, showed an aggressive clinical course in both 
immune-competent and -compromised patients, with 
higher requirements of surgical intervention and mortal-
ity. It was also seen that the clinical course of Mucor was 
more fulminant with greater mortality and morbidity than 
Aspergillus. 
The difference in clinical predilection was also re-
flected in the imaging findings, with bacterial SBO show-
ing predominant involvement of the EAC, along with the 
middle ear or mastoid air cells occasionally (Figure 2A, 
B, D). Similarly, disease extension into deep tissues was 
also seen to differ among the groups. While bacterial SBO 
Figure 3. 54-year-old female with rhino-orbito-cerebral mucormycosis. A) Coronal T2 FS MR shows the mucosal thickening in the left maxillary and ethmoid 
sinuses (arrows). T2 hyperintensity and fat stranding is seen in the orbit and deep tissues (solid arrow). B) Post-operative axial T2 WI shows dural thickening 
with convexity in the left cavernous sinus (solid arrow). The left cavernous ICA flow void is not visualised, compared with right cavernous ICA (arrows). 
Patient had undergone maxillectomy, ethmoidectomy and orbital exenteration (*). C) TOF MRA maximum intensity projection shows non visualisation 
of the left ICA (solid arrow) and narrowing of the left ACA and MCA with paucity of their distal branches (arrows). D) Axial T2w MR shows hyperintensity in 
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was limited anteriorly by the pharyngobasilar fascia, the 
spread of fungal SBO was seen further anteriorly, predom-
inantly into the pterygopalatine fossa and subcutaneous 
tissue of cheek and face region (Figure 3A). Ethmoid sinus 
was the most frequently affected among the paranasal si-
nuses, by both Aspergillus and Mucor. Mucosal thicken-
ing was seen more commonly than complete opacification 
or air-fluid levels, probably because of the early spread 
of fungal disease and hence early presentation with overt 
patient symptoms. The path of least resistance for further 
spread of infection lies across the lamina papyracea to the 
orbit, followed by the orbital apex and then to the cav-
ernous sinus, which is responsible for the corresponding 
clinical and radiological manifestations of orbital, cavern-
ous sinus and cavernous ICA involvement [2] (Figure 3B, 
C, D). This lends itself to a natural classification, whereby 
increasing severity is indicated by rhinosinusitis, sino-or-
bital, and sino-orbito-cranial forms [24] (Figure 4A, B, C). 
However, there have been reports of Aspergillus migrating 
across the cribriform plate directly into the anterior cra-
nial fossa. The postulated mechanism for this is migration 
along the perivascular spaces and spread from the PNS 
even without frank bony destruction [23]. Thus, there 
was higher incidence of sino-cranial spread in Aspergil-
lus SBO, with many reporting seemingly non-contiguous 
extra-axial intracranial masses (Figure 4D). 
Patterns of bone destruction were also peculiar to each 
organism, although erosion and sequestra formation are 
seen in both bacterial and fungal SBO (Figures 2A and 
5). Osteomyelitis in bacterial SBO represents progression 
from cellulitis to osteitis and finally osteomyelitis [25]. 
Thus, involvement of pneumatised trabecular bone is late 
and may show formation of abscess cavities [19]. Infection 
spreads to involve the periosteum, leading to periosteal 
elevation and reaction. Absence of periosteal elevation 
from the orbital wall has been described as a predictor for 
Figure 4. Aspergillus skull base osteomyelitis (SBO) (sino-orbital and sino-cranial aspergillosis). A-C) 22-year-old female with sino-orbital aspergillosis. 
A) Axial unenhanced computed tomography (CT) shows opacification of the left ethmoid air cells (solid arrow) with a hyperdense mass lesion seen extending 
into the ipsilateral orbit (arrows) causing proptosis. B) Coronal reformatted image shows the orbital extension (*). There is opacification of the maxillary 
and ethmoid sinuses with dehiscence of the inferior wall of left orbit (solid arrow) and intra-orbital extension. Foci of calcification are also noted (arrows). 
C) Axial T2w MR shows a lobulated, T2 hypointense mass in the retrobulbar space of the left orbit (solid arrow). Mucosal thickening in the anterior ethmoid 
air cells (arrow). D) 21-year-old male with sino-cranial aspergillosis. Coronal T1 FS post gad image shows enhancement of the clivus (arrows) and the left 
muscles of mastication (*). There is extension of enhancing soft tissue into the left cavernous sinus (solid arrow). In addition, a bright enhancing dural based 
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fungal aetiology in the past [26]. In addition, due to the 
invasive nature of the organisms in fungal SBO, there is 
a rapid spread of infection through the Haversian system 
of bone, which gives rise to a permeative pattern of bone 
destruction (Figure 5). Rarefaction was also seen. Thus, 
absence of periosteal elevation with presence of perme-
ative destruction is a strong predictor for fungal aetiology. 
The diagnosis of fungal SBO on MR was also facili-
tated by its characteristic signal on pulse sequences. There 
was a striking hypointensity on T2-weighted sequences 
(Figure 4C), with blooming often seen on the gradient 
echo sequences. This is due to the metabolism of organ-
isms, which concentrates ferromagnetic elements (iron, 
manganese, zinc) within the fungal elements [27]. This is 
also the reason behind their hyperdense appearance on 
CT scans. Calcification was also noted in fungal sinusitis 
in a few studies [11,12] (Figure 4B), which has been pos-
tulated to be dystrophic calcification due to deposition of 
minerals over the necrotic tissue [28]. 
While both fungal species are angio-invasive, there is 
marked propensity of Mucor to cause invasive thrombo-
sis of vessel walls [29] and hence produce both clinically 
as well as radiologically the ‘black turbinate’ comprising 
necrotic eschar tissue. The imaging correlate of this does 
not enhance on administration of intravenous iodinated or 
gadolinium contrast [30]. Other patterns of enhancement 
were also seen; notably, central or patchy irregular non-en-
hancement, presumably due to non-uniform distribution of 
necrotic lesions. On the other hand, Aspergillus commonly 
produces dural based intracranial masses, which are com-
posed of fungal elements and are homogenous in appear-
ance. The enhancement paralleled their composition and 
bright, uniform enhancement was seen [11] (Figure 4D). 
There were certain limitations to our study. There were 
only a few studies that satisfied our inclusion criteria. Of 
these, there were only 2 studies that addressed head-to-
head comparisons among any 2 of these entities; hence, 
we had to extrapolate the data obtained from studies de-
tailing individual aetiologies to derive any possible dif-
ferentiation between the entities. A meta-analysis could 
not be performed due to heterogeneity of data. There was 
often lack of complete information on one or the other pa-
rameters in most of the studies. In addition, the majority 
of the studies were at risk of bias due to their retrospective 
nature; hence, more prospective studies investigating our 
review question should be performed in future. 
Conclusions
The chief differentiating features between bacterial 
and fungal SBO are in terms of presentation and radio-
logical involvement. Bacterial SBO is mostly of otogenic 
origin with involvement of CNs VII-XII; while in fungal 
SBO origin is rhinogenic, with higher incidence of orbital, 
vascular and intracranial extension, palsy of CN III-VI, 
and permeative bone destruction. Hypointensity on 
T2-weighed MR sequences and hyperdensity on unen-
hanced CT also favours fungal involvement. Mucorales 
SBO, in comparison with Aspergillus SBO, shows faster 
disease progression, black eschar, cerebral infarcts, and het-
erogenous post-contrast enhancement. On the other hand, 
Aspergillus SBO shows intracranial homogenous enhancing 
masses and greater incidence of concurrent pulmonary in-
volvement. These are detailed in Tables 4 and 5. Systematic 
analysis of imaging features, aided by relevant clinical in-
formation, may thus allow us to make a reasonably accurate 
diagnosis for prompt targeted therapy as well as accurate 
prognostication of patients. 
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Figure 5. 65-year-old male with fungal skull base osteomyelitis (SBO). A) MIP axial bone window computed tomography shows permeative destruction 
involving the right zygoma and pterygoid bone (arrows). Sequestrum formation is seen along the anterior and laterall walls of maxillary sinus (solid arrow). 
B) In a cranial section, extensive permeative destruction seen involving the right lesser wing of sphenoid (arrows). There is associated mucosal thickening in 
the ethmoid air cells (*) and sphenoid sinus (arrowhead). Soft tissue is seen in the right orbit extending till the orbital apex (solid arrows)
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Immunosuppression + +/– (as in cases  
of Aspergillus SBO)
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Less common More common
Treatment strategy IV antibiotics 
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Amphotericin B + 
Itraconazole + Surgery 
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MR signal T2 hyperintense T2 hypointense +/– 
blooming on GRE
CT attenuation Hypodense Hyperdense +/– 
calcification
Intracranial extension No Yes
Vascular involvement No Yes
SBO – skull base osteomyelitis, EAC – external auditory canal, EOM – extra ocular muscle, 
ON – optic nerve, GRE – gradient echo
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